Publication | Open Access

Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

OncologyArbeitsgemeinschaft Internistische OnkologiePancreatic CancerPharmacologyCancer TreatmentMedicineChemonaive Patients24-H Infusion